Moderna, a biotech company known for its groundbreaking Covid vaccine, faced a setback as the Food and Drug Administration (FDA) announced the delay of its approval for the respiratory syncytial virus (RSV) vaccine until the end of May. This unexpected delay was attributed to “administrative constraints” at the agency, causing a ripple of concern among
Business
The upcoming boxing match between Mike Tyson and Jake Paul this summer has already sparked a frenzy among fans and bettors alike. The bout is scheduled for July 20 at AT&T Stadium in Arlington, Texas and will be streamed globally on Netflix. This highly anticipated fight is expected to be the most heavily bet on
The absence of a Marvel film to kick off the summer movie season in 2024 marks a significant deviation from the trend seen in previous years. Marvel Cinematic Universe has been a dominant force in the summer box office since the release of “Iron Man” in 2008. However, in 2024, Universal’s “The Fall Guy” took
Oddity Tech, an Israeli cosmetics platform utilizing artificial intelligence to innovate products, reported exceptional first-quarter results that surpassed expectations. The company’s earnings per share were 61 cents, adjusted, compared to the 49 cents anticipated by Wall Street analysts. Revenue also exceeded expectations, coming in at $211.63 million versus the projected $205 million. This impressive performance
Former Starbucks CEO, Howard Schultz, has expressed his belief that the company can recover from its recent downturn by improving its U.S. stores. He emphasized the need for a “maniacal focus on the customer experience, through the eyes of a merchant,” rather than relying solely on data. This suggests that Starbucks may have lost touch
Amgen’s stock surged by more than 12% on Friday following the drugmaker’s announcement of positive initial data on its experimental weight loss injection, MariTide. This news sparked concerns among investors about new competition in the rapidly growing weight loss drug industry. The shares of current obesity players, Novo Nordisk and Eli Lilly, took a hit
Wayfair, the online furniture giant, recently reported a decline in sales during its first quarter. However, this setback was accompanied by a reduction in losses, thanks to a strategic decision to cut 13% of its workforce earlier in the year. Despite this, the company managed to surpass Wall Street’s expectations on both the top and
Johnson & Johnson recently announced a settlement plan to pay $6.5 billion over 25 years to resolve thousands of lawsuits in the U.S. that claim their talc-based products caused ovarian cancer. This move comes after decades of legal and public relations turmoil for the company. They firmly believe that their talc products are safe for
In a surprising turn of events reminiscent of a high-stakes drama series, Paramount Global is gearing up to make a significant change at the top. Chief Executive Officer Bob Bakish is reportedly on his way out, with a group of current division heads poised to take over the reins. This move, set to be announced
The Food and Drug Administration recently gave their seal of approval to Pfizer’s revolutionary treatment for hemophilia B, a rare genetic bleeding disorder that affects thousands of people in the United States. This groundbreaking gene therapy, known as Beqvez, represents Pfizer’s first foray into the gene therapy market in the U.S. The approval of Beqvez